What is Neurocrine Biosciences's PP&E (net)?

Neurocrine Biosciences (NBIX) reported PP&E (net) of $90.9M in Q1 2026.

How has Neurocrine Biosciences's PP&E (net) changed year-over-year?

Neurocrine Biosciences's PP&E (net) increased by 4.5% year-over-year, from $87M to $90.9M.

What is the long-term trend for Neurocrine Biosciences's PP&E (net)?

Over 5 years (2020 to 2025), Neurocrine Biosciences's PP&E (net) has grown at a 15.0% compound annual growth rate (CAGR), from $44.6M to $89.8M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Neurocrine Biosciences NBIX PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.79B+5.7%

Acadia PharmaceuticalsACAD

$14.65M+319%

Crinetics PharmaceuticalsCRNX

$13.5M+6.9%

Solid Biosciences Inc.SLDB

$3.91M-12.7%

MapLight Therapeutics, Inc. MPLT

$968K—

BridgeBio PharmaBBIO

$4.94M-26.2%

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$18.38B+38.4%

Enterprise value$18.57B+37.6%

P/E27.5×-10.6×

P/S5.9×+0.6×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's PP&E (net)?: Neurocrine Biosciences (NBIX) reported PP&E (net) of $90.9M in Q1 2026.
How has Neurocrine Biosciences's PP&E (net) changed year-over-year?: Neurocrine Biosciences's PP&E (net) increased by 4.5% year-over-year, from $87M to $90.9M.
What is the long-term trend for Neurocrine Biosciences's PP&E (net)?: Over 5 years (2020 to 2025), Neurocrine Biosciences's PP&E (net) has grown at a 15.0% compound annual growth rate (CAGR), from $44.6M to $89.8M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.